Locations:
Search IconSearch
September 20, 2017/Cancer/News & Insight

ASTRO 2017 – Tuesday, September 26

Please join our staff as we participate or present in the following oral and poster presentations at the 2017 ASTRO Annual Meeting

17-CNR-4279_650x450

Tuesday, September 26

Poster Viewing Q&A 5: Lung, Pediatrics, Education
Hall A-B1, Ground Level
1PM

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Poster Q&A
Ehsan Balagamwala, MD
Comprehensive Analysis of Toxicity and Pulmonary Function Tests in Patients Undergoing Repeat Lung Stereotactic Body Radiation Therapy (SBRT) After Initial Lung SBRT

Poster Q&A
Bindu Manyam, MD
Single Fraction SBRT for Stage I Non-Small Cell Lung Cancer: Treatment Outcomes and Effect of Tumor Location on Chest Wall Toxicity

Poster Viewing Q&A 6: CNS, Head and Neck, Sarcoma
Hall A-B1, Ground Level
2:45PM

Poster Q&A
Jonathan Sharrett, MD
Tumor Volume is a Better Predictor of Locoregional Failure than T and N Staging in Larynx Cancer Patients Treated with Definitive Chemoradiation

Poster Q&A
Rupesh Kotecha, MD
Personalized Radiosurgery for Brain Metastasis: Moving beyond Tumor Size in the Modern Stereotactic Radiosurgery Era

Poster Q&A
Charles Leyrer, MD
An Evaluation of Prognostic Factors of Elderly Patients with Low Grade Glioma

Poster Q&A
Taoran Cui, MD
A 7-Year Institutional Experience in Dosimetric Quality Improvement for Oropharyngeal Cancer: Progress to Date

Poster Q&A
Shlomo Koyfman, MD
Refining Risk Stratification in HPV-Related Oropharynx Cancer: Implications for Clinical Trials

Poster Q&A
Matthew Ward, MD
One-Size Does Not Fit All: Planning Objectives with IG-VMAT for Oropharynx Cancer and Guidelines by Clinical Context

Poster Viewing Q&A 7: GI, Patient Safety, Hematologic
Hall A-B1, Ground Level
4:45PM

Poster Q&A
Timothy Meier
Presimulation Procedure Safety Checklist/Time Out Reduces Simulation Related Unintended Deviations

Poster Q&A
Ehsan Balagamwala, MD
Intraoperative Radiation Therapy for the Treatment of Locally Advanced and Recurrent Abdominopelvic Tumors

Advertisement

Poster Q&A
Ehsan Balagamwala, MD
T1N0 Esophageal Cancer: A Patterns of Care and Survival Analysis

Poster Q&A
Camille Berriochoa, MD
The Role of Adjuvant Therapy for Patients with Early Esophageal Cancer Who Are Pathologically Upstaged Following Esophagectomy: An NCDB Analysis

Poster Q&A
Camille Berriochoa, MD
Definitive Radiation Therapy for Patients with Metastatic Esophageal Squamous Cell Carcinoma Improves Survival: An NCDB Analysis

Poster Q&A
Charles Leyrer, MD
The Importance of Standardization in Workflow Enhancement and Patient Safety

Poster Q&A
Ping Xia, PhD
Intersystem variability of Kilovoltage Conebeam Computed Tomography Imaging Guidance for Patients with Head and Neck Cancer: An NRG Oncology Multiple Institution study

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad